IBM reported a net income of $5.6bn for the fourth quarter of 2025 (Q4 2025), representing a 93.1% increase from $2.9bn in the same period of the previous year. The company’s revenue for the fourth quarter ended 31 December 2025 was $19.7bn, marking a 12% increase compared to $17.6bn in Q4 2024. For the full year 2025, the company's net income reached $10.6bn, a 76.7% increase compared to $6bn in 2024. IBM's revenue for the full year 2025 reached $67.5bn, an 8% rise compared to $62.7bn in the previous ...

on 28-Jan-2026 Global Capital Goods LONG VIEW 28 January 2026 Powering AI: Deep diving the 800 VDC shift - quantifying the impact on electricals content and growth Alasdair Leslie +44 20 7762 4952 alasdair.leslie@bernsteinsg.com +44 20 7550 2192 om.kela@bernsteinsg.com Chad Dillard +1 917 344 8469 chad.dillard@bernsteinsg.com Miguel Marques, CFA +1 917 344 8432 miguel.marques@bernsteinsg.com +44 20 7762 1411 nicholas.witting@bernsteinsg.com Dan Corcuera-Robbins, ACA +44 20 7762 5184 dan.corcuera-robbins@ber ...

Core Insights - Walmart has returned a total of $132 billion to its investors over the past ten years through dividends and buybacks, ranking it as the 13th highest in shareholder returns in history [2][3] - The company has achieved this while expanding revenue, investing in e-commerce, automation, and logistics, and maintaining a conservative balance sheet [3] - Dividends and share repurchases indicate management's confidence in financial stability and sustainable cash flows [4] Financial Metrics - Walmart's revenue growth stands at 4.3% for the last twelve months (LTM) and an average of 5.4% over the past three years [8] - The company has a free cash flow margin of approximately 2.2% and an operating margin of 4.1% LTM [8] - Walmart's stock trades at a price-to-earnings (P/E) ratio of 41.7 [8] Market Position - The total capital returned to shareholders as a percentage of market cap appears inversely related to growth potential for reinvestments, with companies like Meta and Microsoft showing faster growth but returning a smaller portion to shareholders [5] - High capital returns raise questions about potential compromises in growth and fundamentals [6]

Core Viewpoint - Inno Holdings Inc. has announced an At-the-Market equity offering sales agreement to sell shares of its Common Stock valued up to $50 million, with proceeds intended for general working capital and corporate purposes [1][3]. Group 1: Offering Details - The Company may sell shares through its sales agent, Aegis Capital Corp., at prevailing market prices, with the timing and volume of sales determined at the Company's discretion [1][2]. - The offering will be conducted under the existing effective shelf registration statement filed with the U.S. Securities and Exchange Commission (SEC) [3]. Group 2: Company Overview - Inno Holdings Inc. focuses on building technology and electronic products trading, aiming to revolutionize the construction industry with proprietary cold-formed steel framing, AI-driven design, and automation [7]. - The Company is expanding its sales and distribution network to create greater commercial value for its business partners and enhance its own enterprise value [7].

Company Overview - CMCO's Total Addressable Market (TAM) is estimated at $34 billion[11] - The company's TTM Net Sales are $978 million[11] - The company's TTM Adjusted EBITDA Margin is approximately 15%[11] - The company's TTM Free Cash Flow Conversion is greater than 100%[11] - Lifting Solutions account for 62% of the company's revenue[24] Kito Crosby Acquisition - Kito Crosby's 2024 Revenue is $1.1 billion[37] - Kito Crosby's revenue CAGR from 2021-2024 is 7%[37] - Lifting & Securement Consumables account for 54% of Kito Crosby's revenue[38] - North America accounts for 56% of Kito Crosby's revenue[37] Financial Performance - The company's Adjusted EBITDA is $142.047 million[52] - The company's Free Cash Flow (FCF) is $29.365 million[55]

Financial Performance - Ginkgo's Q3 2025 total revenue was $39 million, a decrease of 56% year-over-year compared to $89 million in Q3 2024[34] - Cell Engineering revenue in Q3 2025 was $29 million, a 61% decrease compared to $75 million in Q3 2024, which includes $45 million of non-cash deferred revenue from Motif[23, 34] - Biosecurity revenue in Q3 2025 was $9 million, a 32% decrease compared to $14 million in Q3 2024[34] - Total Adjusted EBITDA for Q3 2025 was $(56) million, compared to $(20) million in Q3 2024[34] - Ginkgo reaffirms its full year 2025 total revenue guidance of $167-187 million[43] - Ginkgo's cash, cash equivalents, and marketable securities remain strong at $462 million as of Q3 2025[17] - Quarterly cash burn continues to improve, with a 73% decrease from the prior quarter[14] Strategic Focus - Ginkgo is expanding its business model into life science tools and services[54, 96] - Ginkgo believes AI models will impact biotechnology in two ways and is well-positioned to provide tools in both[48, 51, 93, 115] - Ginkgo continues to offer research solutions on top of its in-house robotics, winning new deals in Agriculture and with the US Government[49, 52, 94, 116] - Ginkgo is expanding its frontier autonomous lab in Boston as a showcase[50, 53, 95, 117, 118]

Core Insights - Ranpak Holdings reported a net loss of $10.4 million for Q3 2025, compared to a net loss of $8.1 million in the same quarter of 2024 [1][3] - Net revenue for Q3 2025 increased by 8% year-on-year to $99.6 million, or 4.4% on a constant-currency basis, driven by automation, void-fill, and wrapping product lines [1][2] Revenue Breakdown - Cushioning revenue rose by 0.3%, void-fill increased by 4.8%, and wrapping grew by 9% [2] - Automation net revenue saw the largest gain, up 63%, attributed to a 4.5% rise in automated equipment sales [2] Cost and Earnings Management - Adjusted earnings before interest, taxation, depreciation, and amortisation improved by 8.1% year-on-year, or 3.5% on a constant-currency basis, due to top-line leverage and disciplined cost management [3] - The company closed the quarter with a cash balance of $49.9 million and no draws on its $50 million revolving credit facility, maturing in December 2029 [3] Strategic Partnerships - The CEO stated that the third quarter was a significant step towards achieving long-term growth, highlighted by a partnership and warrant agreement with Walmart [4] - The Walmart agreement is estimated to imply up to roughly $700 million in total spend over the life of the contract for full vesting, excluding the cost of paper [5]

Core Points - Ginkgo Bioworks Holdings, Inc. plans to host a presentation and Q&A session on November 6, 2025, to review its business performance for Q3 2025 [1][2] - The presentation will be accessible via Ginkgo's investor relations website, and a replay will be available afterward [2] - Ginkgo Bioworks focuses on making biology easier to engineer, offering customizable R&D solutions, laboratory automation, and biosecurity technologies [3] Company Overview - Ginkgo Bioworks builds tools for biological engineering, providing R&D packages that include protein engineering and nucleic acid design [3] - The company also offers modular laboratory automation to enhance scientists' productivity [3] - Ginkgo Biosecurity is developing infrastructure to address biological threats globally [3]

Core Insights - IBM reported $16.33 billion in revenue for Q3 2025, a year-over-year increase of 9.1%, with EPS of $2.65 compared to $2.30 a year ago, exceeding Zacks Consensus Estimates for both revenue and EPS [1][2] Revenue Breakdown - Software revenue was $7.21 billion, slightly below the average estimate of $7.27 billion, reflecting a year-over-year increase of 10.5% [4] - Consulting revenue reached $5.32 billion, surpassing the average estimate of $5.24 billion, with a year-over-year change of 3.3% [4] - Financing revenue was reported at $200 million, exceeding the average estimate of $171.23 million [4] - Infrastructure revenue was $3.56 billion, above the estimated $3.42 billion, showing a significant year-over-year increase of 17% [4] - Other revenue was $38 million, compared to an average estimate of -$6.47 million, indicating a year-over-year decline of 44.1% [4] - Intelligent Operations revenue was $2.4 billion, exceeding the average estimate of $2.34 billion [4] - Automation revenue was $1.9 billion, above the average estimate of $1.78 billion [4] - Strategy and Technology revenue was $2.9 billion, slightly above the estimated $2.87 billion [4] - Hybrid Cloud revenue was $1.9 billion, below the average estimate of $1.99 billion [4] - Infrastructure Support revenue was $1.3 billion, exceeding the average estimate of $1.27 billion, with no change year-over-year [4] - Data revenue was $1.5 billion, slightly above the average estimate of $1.47 billion [4] - Transaction Processing revenue was $1.9 billion, below the average estimate of $2.05 billion, with no change year-over-year [4] Stock Performance - IBM shares returned +3.6% over the past month, outperforming the Zacks S&P 500 composite's +1.1% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Company Overview - Columbus McKinnon (CMCO) has a total addressable market of $20 billion[7] - CMCO's net sales are approximately $1 billion[7] - CMCO's 5-year sales growth CAGR is approximately 4%[7] - CMCO's adjusted EBITDA margin is approximately 15-16%[7] Kito Crosby Acquisition - Kito Crosby's 2024 revenue was $1.1 billion[35] - Kito Crosby's revenue CAGR from 2021 to 2024 was 7%[35] - Kito Crosby serves over 600,000 end-users[35] Financial Performance - In FY24, CMCO's net income was $46.625 million, with an adjusted EBITDA of $166.653 million and an adjusted EBITDA margin of 16.4%[52] - In FY25, CMCO's net loss was $5.138 million, with an adjusted EBITDA of $150.495 million and an adjusted EBITDA margin of 15.6%[52] - In Q2 FY26, CMCO's net loss was $15.665 million, with an adjusted EBITDA of $143.765 million and an adjusted EBITDA margin of 15.0%[52]